A Controlled Pharmacogenetic Trial of Sibutramine on Weight Loss and Body Composition in Obese or Overweight Adults

This publication has 45 references indexed in Scilit:

• Associations between an alpha 2a adrenergic receptor gene polymorphism and adolescent personality
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2008
• Genes Implicated in Serotonergic and Dopaminergic Functioning Predict BMI Categories
  Obesity, 2008
• Contribution of the Functional 5‐HTTLPR Variant of the SLC6A4 Gene to Obesity Risk in Male Adults
  Obesity, 2008
• Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations
  Metabolism, 2007
• Possible involvement of alpha‐2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
• Serotonin transporter gene (5-HTTLPR) and major psychoses
  Molecular Psychiatry, 2002
• Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial
  International Journal of Obesity, 2001
• 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people
  International Journal of Obesity, 2000
• Assessing motivational readiness and decision making for exercise.
  Health Psychology, 1992
• The Hospital Anxiety and Depression Scale
  Acta Psychiatrica Scandinavica, 1983